Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
---|
04/14/2005 | US20050080117 Substituted benzoxazoles as estrogenic agents |
04/14/2005 | US20050080058 New vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments |
04/14/2005 | US20050079529 Using laser excitation and fluorescence to identify regions of hybridization along microarray comprised of immobilized polynucleotides; gene expression analysis; genomics |
04/14/2005 | US20050079381 Rubrene derivatives emit blue light; glass substrate supports a hole injecting layer, a hole transporting layer, and a light emitting layer |
04/13/2005 | EP1522313A1 Combination therapy of radiation and valdecoxib for the treatment of neoplasia |
04/13/2005 | EP1073640B1 Naphthalene derivatives, their production and use |
04/13/2005 | CN1196687C Inhibitors of IMPDH enzyme |
04/12/2005 | US6878743 Controlling apoptosis; central nervous system disorders |
04/12/2005 | US6878739 Composition for treating or preventing glomerulopathy |
04/12/2005 | US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough |
04/12/2005 | CA2174107C Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones |
04/12/2005 | CA2128380C 4-aryloxy- and 4-arylthiopiperidine derivatives |
04/12/2005 | CA2122571C Adhesion receptor antagonists |
04/07/2005 | WO2005030739A1 Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof |
04/07/2005 | WO2005030736A1 Derivatives of 1,3-diones having a herbicidal activity |
04/07/2005 | WO2005030705A1 Inhibitors of histone deacetylase |
04/07/2005 | WO2005030704A1 Inhibitors of histone deacetylase |
04/07/2005 | WO2005030700A2 Amino acids with affinity for the alpha2delta-protein |
04/07/2005 | WO2005016898A3 Stable polymorph of bifeprunox mesilate |
04/07/2005 | WO2004014871A8 Vanilloid receptor ligands and their use in treatments |
04/07/2005 | US20050075506 Process for preparing florfenicol |
04/07/2005 | US20050075505 Reacting 3-(3,5-dimethylphenoxy)-2-hydroxypropylamine with such as ethyl chloroformate under alkaline conditions; high yield; reduced energy |
04/07/2005 | US20050075382 Compounds as bactericides or drugs |
04/07/2005 | US20050075381 a [4-(5-phenyl)oxazolyl]-N-acetyl pyrrolidine or a [1-amino-2-hydroxy-2-phenylethyl]-N-acetyl pyrrolidine; enzyme inhibitors; anticarcinogenic, antitumor agents |
04/07/2005 | US20050075380 Composition comprising at least one oxazolin for inhibiting langerhans cell migratio, and uses thereof |
04/07/2005 | US20050075378 Modulators of peroxisome proliferator activated receptors (ppar) |
04/07/2005 | US20050075367 Ester compound and medicinal use thereof |
04/07/2005 | US20050075338 5-(Substituted oxazolyl- or thiazolyl-ethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
04/07/2005 | US20050075323 Beta3 adrenergic receptor agonists and uses thereof |
04/07/2005 | CA2540208A1 Amino acids with affinity for the alpha2delta-protein |
04/07/2005 | CA2539744A1 Derivatives of 1,3-diones having a herbicidal activity |
04/07/2005 | CA2539117A1 Inhibitors of histone deacetylase |
04/07/2005 | CA2537877A1 Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof |
04/06/2005 | EP1520856A1 Androgen receptor agonist |
04/06/2005 | EP1519932A1 Bisarylsulfonamide compounds and their use in cancer therapy |
04/06/2005 | EP1519925A1 Oxazole derivatives and their use as insulin sensitizers |
04/06/2005 | EP1519924A1 Difluorothioacetamides of oxazolidinones as antibacterial agents |
04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
04/06/2005 | EP1519722A1 Glycoloyl-substituted oxazolidinone-derivatives as antibacterial agents |
04/06/2005 | EP1406898B1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
04/06/2005 | EP1250299B1 Chiral ionic liquids |
04/06/2005 | EP1135349B1 Process for preparing chiral compounds |
04/06/2005 | CN1603315A Method for preparing oxazolidine |
04/06/2005 | CN1195762C Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
04/06/2005 | CN1195753C Fused-benzene derivatives useful as herbicides |
04/06/2005 | CN1195746C Preparation method of N-carboxy anhydride |
04/06/2005 | CN1195734C Phthalamide derivs., intermediates in production thereof, and agricultural/horticultural insecticides and method of using same |
04/05/2005 | US6875874 Using thionyl chloride |
04/05/2005 | US6875871 Oxazolidinone photoaffinity probes |
04/05/2005 | US6875785 Nonsteroidal antiinflammatory agents, e.g., N-hydroxy-1-(4-sulfonyl or aminosulfonyl)phenyl)-(ring- substituted hetero-cyclyl)alkanamide or -urea; dual enzyme inhibitors with minimal side effects; asthma; antiallergens; antipyretics |
04/05/2005 | US6875782 Antidiabetic agents, dietetics, anticancer agents |
04/05/2005 | US6875768 Phthalamide derivatives, intermediates in the production thereof, and agricultural/horticultural insecticides and method for using the same |
03/31/2005 | WO2005028454A1 Haloalkyl containing compounds as cysteine protease inhibitors |
03/31/2005 | WO2005028445A2 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain |
03/31/2005 | WO2005028426A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor |
03/31/2005 | WO2005028413A1 Process for producing optically active cyclopropane compound and asymmetric copper complex for use in the same |
03/31/2005 | WO2004108133A3 Modulators of vr1 receptor |
03/31/2005 | WO2004098591A3 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases |
03/31/2005 | WO2004073606A3 Sulfonamide derivatives as ppar modulators |
03/31/2005 | US20050070719 Central nervous system disorders; antidiabetic agents; antiinflammatory agents; antiarthritic agents;obesity; osteoporosis ; anticancer agents |
03/31/2005 | US20050070533 Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use |
03/31/2005 | US20050070532 Peroxisome proliferator activated receptors (PPARS); for inhibiting formation of adipocytes; for treatment of obesity, diabetes, hyperinsulinemia, and polycystic ovary syndrome |
03/31/2005 | US20050070526 Novel antibacterial agents |
03/31/2005 | CA2539554A1 Phenylacetic acid derivative, process for producing the same, and use |
03/31/2005 | CA2539306A1 Haloalkyl containing compounds as cysteine protease inhibitors |
03/31/2005 | CA2538454A1 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain |
03/30/2005 | EP1517974A1 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use |
03/30/2005 | EP1517907A2 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity |
03/30/2005 | EP1517881A1 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives |
03/30/2005 | EP1307182B1 Pharmaceutical composition for transdermal delivery of befloxatone |
03/30/2005 | EP1237551B1 Pharmaceutical formulations containing zolmitriptan |
03/30/2005 | EP0586385B2 Enantiomer separating process on chiral separation phases by means of a continuous counter-current chromatography process |
03/30/2005 | CN1602341A 树脂组合物 Resin composition |
03/30/2005 | CN1602290A Process for the synthesis of chirally pure beta -amino-alcohols |
03/30/2005 | CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
03/30/2005 | CN1194964C P-methylsulfonyl phenylacrylate derivative and its prepn process and anti-inflammatory effect |
03/30/2005 | CN1194960C Method for preparing 4,5-diamino shikimic acid derivative |
03/24/2005 | WO2005026137A2 Modulators of atp-binding cassette transporters |
03/24/2005 | WO2005026134A1 Organic compounds |
03/24/2005 | WO2005026114A1 Hiv protease inhibitors, compositions containing the same and their pharmaceutical uses |
03/24/2005 | WO2005012220A3 Cycloalkylidene compounds as modulators of estrogen receptor |
03/24/2005 | WO2005005456A3 Peptide deformylase inhibitors |
03/24/2005 | US20050065353 Mitosis agents; antitumor agents; anticancer agents |
03/24/2005 | US20050065350 Method for forming a carbon-carbon or carbon-heteroatom linkage |
03/24/2005 | US20050065340 Psychological disorders; anxiolytic agents; antidepressants; analgesics ; schizophrenia |
03/24/2005 | US20050065198 Inhibitors of 15-lipoxygenase |
03/24/2005 | US20050065187 Novel antimicrobial aryloxazolidinone compounds |
03/24/2005 | CA2539016A1 Organic compounds |
03/24/2005 | CA2537841A1 Modulators of atp-binding cassette transporters |
03/23/2005 | EP1516877A1 Amine derivatives as protease inhibitors |
03/23/2005 | EP1515944A1 Aspartyl protease inhibitors |
03/23/2005 | EP1515726A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors |
03/23/2005 | EP1515694A1 Benzoxazole and benzodiazole uv-a sunscreens |
03/23/2005 | EP1419125A4 Kinetic resolutions of chirat 3- and 3-substituted carboxylic acids |
03/23/2005 | EP1347969B1 5- (pyrazol-4-yl)carbonyl]benzazolone as herbicide |
03/23/2005 | CN1599729A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
03/23/2005 | CN1599717A Cyclic diamine compounds having fused-ring groups |
03/23/2005 | CN1597673A Paro methylsulfonyl phongl acrylic acid derivative and its preparation method and antiinflammation action |
03/23/2005 | CN1597672A Substituierte benzoylcyclohexandione |
03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |